Living donor liver transplantation in high-risk vs. low-risk patients: Optimization using statistical models

被引:11
作者
Durand, F
Beighiti, J
Troisi, R
Boillot, O
Gadono, A
Francoz, C
de Hemptinne, B
Mallet, A
Valla, D
Golmard, JL
机构
[1] Hop Beaujon, INSERM, U481, Serv Hepatol, F-92110 Clichy, France
[2] Hop Beaujon, Digest Surg Unit, F-92110 Clichy, France
[3] Ghent Univ Hosp, Digest Surg Unit, B-9000 Ghent, Belgium
[4] Hop Edouard Herriot, Lyon, France
[5] Italian Hosp, Buenos Aires, DF, Argentina
[6] Grp Hosp Pitie Salpetriere, INSERM, U436, F-75634 Paris, France
关键词
D O I
10.1002/lt.20700
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Living donors represent a recognized alternative for facilitating the access to transplantation in a period of organ shortage. However, which candidates should be preferentially considered for living-donor liver transplantation (LDLT) is debated. The aim of this study was to create statistical models to determine which strategies of selection for LDLT provide the most efficient contribution. The study included 331 patients listed for deceased-donor transplantation (DDLT) and 128 transplanted with living donors. Statistical models predicting the events following listing were created and combined in a multistate model allowing the testing of different strategies of selection for LDLT and to compare their results. Taking 3-yr survival after listing as the principal end-point, selecting the 20% patients at highest risk of death on the waiting list gave better results than selecting the 20% patients at lowest risk of death after LDLT (70% vs. 64%, respectively). These strategies resulted in waiting list mortality rates of 17% and 8%, respectively. One-year survival after LDLT was lower in high-risk patients (85%) than in low-risk patients (91 %). However, the 1-yr survival benefit derived from LDLT was 75% in high-risk patients while it was nil in low-risk patients. In conclusion, LDLT is more effective for overcoming the consequences of organ shortage when performed in patients at high risk of death on the waiting list. On an individual basis, the sickest patients are those who derive the most important benefit from LDLT. This study provides incentives for considering LDLT in high-risk patients.
引用
收藏
页码:231 / 239
页数:9
相关论文
共 25 条
[1]
Predicting survival among patients listed for liver transplantation: An assessment of serial MELD measurements [J].
Bambha, K ;
Kim, WR ;
Kremers, WK ;
Therneau, TM ;
Kamath, PS ;
Wiesner, R ;
Rosen, CB ;
Thostenson, J ;
Benson, JT ;
Dickson, ER .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (11) :1798-1804
[2]
A survey of liver transplantation from living adult donors in the United States [J].
Brown, RS ;
Russo, MW ;
Lai, M ;
Shiffman, ML ;
Richardson, MC ;
Everhart, JE ;
Hoofnagle, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (09) :818-825
[3]
Living-donor liver transplantation: 12 years of experience in Asia [J].
Chen, CL ;
Fan, ST ;
Lee, SG ;
Makuuchi, M ;
Tanaka, K .
TRANSPLANTATION, 2003, 75 (03) :S6-S11
[4]
Predicting outcome after liver transplantation: Utility of the model for end-stage liver disease and a newly derived discrimination function [J].
Desai, NM ;
Mange, KC ;
Crawford, MD ;
Abt, PL ;
Frank, AM ;
Markmann, JW ;
Velidedeoglu, E ;
Chapman, WC ;
Markmann, JF .
TRANSPLANTATION, 2004, 77 (01) :99-106
[5]
Devlin J, 1999, GUT, V45, P1
[6]
Results of the first year of the new liver allocation plan [J].
Freeman, RB ;
Wiesner, RH ;
Edwards, E ;
Harper, A ;
Merion, R ;
Wolfe, R .
LIVER TRANSPLANTATION, 2004, 10 (01) :7-15
[7]
Liver transplant waiting time does not correlate with waiting list mortality: Implications for liver allocation policy [J].
Freeman, RB ;
Edwards, EB .
LIVER TRANSPLANTATION, 2000, 6 (05) :543-552
[8]
Donor and recipient outcomes in right lobe adult living donor liver transplantation [J].
Ghobrial, RM ;
Saab, S ;
Lassman, C ;
Lu, DSK ;
Raman, S ;
Limanond, P ;
Kunder, G ;
Marks, K ;
Amersi, T ;
Anselmo, D ;
Chen, P ;
Farmer, D ;
Han, S ;
Durazo, F ;
Goldstein, LI ;
Busuttil, RW .
LIVER TRANSPLANTATION, 2002, 8 (10) :901-909
[9]
Adult living donor liver transplantation for patients with hepatocellular carcinoma -: Extending UNOS priority criteria [J].
Gondolesi, GE ;
Roayaie, S ;
Muñoz, L ;
Kim-Schluger, L ;
Schiano, T ;
Fishbein, TM ;
Emre, S ;
Miller, CM ;
Schwartz, ME .
ANNALS OF SURGERY, 2004, 239 (02) :142-149
[10]
Harper Ann M, 2002, Clin Transpl, P79